Concepedia
Statistics
Publications
11
Citations
653
H-Index
Active since
1999
Affiliations
Western University(Current)
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases
Center for Drug Evaluation and Research
United States Food and Drug Administration
Mark Paciga is an author at Western University specializing in life sciences, biochemistry, and cell signaling.
Publications per year
1999–2017
FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond
Lee H. Pai-Scherf, Gideon M. Blumenthal, Hongshan Li et al. · The Oncologist · 2017 · 292 citations · Full text
Medicine, Oncology, Pharmacology +16
FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma
Meredith K. Chuk, Jennie Chang, Marc R. Theoret et al. · Clinical Cancer Research · 2017 · 89 citations
Medicine, Oncology, Pharmacology +17
Targeting of Big Stanniocalcin and Its Receptor to Lipid Storage Droplets of Ovarian Steroidogenic Cells
Mark Paciga, Christopher R. McCudden, Constantine Londos et al. · Journal of Biological Chemistry · 2003 · 54 citations · Full text
Life Sciences, Biochemistry, Endocrinology +17
Cell-type specific requirements for thiol/disulfide exchange during HIV-1 entry and infection
Tzanko S. Stantchev, Mark Paciga, Carla R Lankford et al. · Retrovirology · 2012 · 41 citations · Full text
Life Sciences, Biochemistry, Infectious Diseases +13
Role of ET-1 in hypoxia-induced mitosis of cultured rat carotid body chemoreceptors
Mark Paciga, Cathy Vollmer, Colin A. Nurse · Neuroreport · 1999 · 40 citations
Life Sciences, Cell Biology, Physiology +14
1–5 of 11